Now Available nation-wide to all electronic medical records (EMRs) and integrated networks (INs)
Houston, Texas (2-15-2012): NewCrop, LLC, announced the completion of their comprehensive electronic prescribing of controlled substances (EPCS) software solution, NewCrop-EPCS. This culminates an 18 month project, beginning with the release of Drug Enforcement Agencies requirements in June 2010.
DEA’s mandate for non-repudiation of electronic prescriptions for controlled substances necessitated a complex foundation of NIST level 3 requirements for registration, authentication, authorization, and legally enforceable digital signatures. NewCrop’s achievement has been to create, despite this complexity, an easily-used and easily-installed software solution.
“Our goal was to meet the complex DEA mandates, yet provide doctors with a transparent prescribing workflow,” said Lawrence Susnow, M.D., President and Chief Medical Officer. “NewCrop-EPCS accomplishes this: doctors can now bring the patient safety and efficiency of electronic prescribing to all narcotics and other scheduled drugs.”
“Of equal importance, NewCrop-EPCS is designed to be easily integrated with a wide variety of EMRs and networks,” said Craig Wagener, Chief Information Officer, NewCrop LLC. “Each has the choice of utilizing our self-installing user interface or of using our data services to seamlessly incorporate individual components into their existing workflow. With final approval from the Surescripts pharmacy network, we will now begin our nation-wide roll out.”
McGladrey Accounting Services completed the mandated assessment of NewCrop-EPCS against the requirements of the Drug Enforcement Agency’s (DEA’s) Interim Final Rule on EPCS for software solution vendors.
“At McGladrey, we understand the value of effective compliance assessment services in an ever-changing and complex regulatory environment. DEA and EPCS is a case in point,” said Doug Underwood, a principal with McGladrey. “We are proud to have confirmed that NewCrop has created all needed controls to provide their e-prescription services to their many clients and prescribing doctors.”
Added Joe Benfatti, Director, McGladrey Technology Risk Advisory Services, “We were pleased to participate in this early-to-market EPCS product release. Furthermore, NewCrop’s modular approach allows an accelerated DEA certification process since we will have already assessed much of the technology. We look forward to assisting NewCrop’s many current and new customers as they quickly roll out EPCS nation-wide.”
NewCrop-EPCS is now available for evaluation and installation nation-wide. It is utilized in 150+ EMRs currently using NewCrop services. It can be easily added as a module to any installed prescribing infrastructure. NewCrop welcomes inquiries from EMRs and INs interested in EPCS or other prescribing services. Contact NewCrop at 888-609-4188 or EPCS@newcroprx.com. We will be demonstrating NewCrop-EPCS and answering questions in the McGladrey booth at HIMSS #6131.
NewCrop LLC provides electronic prescribing systems, delivered over the Internet and designed for incorporation into other electronic medical records and other medical systems. All features are available as a comprehensive user interface or, via data services, as individual components such as the new EPCS module.
McGladrey & Pullen, LLP operates under the McGladrey brand as the fifth largest U.S. provider of assurance, tax and consulting services, with nearly 6,500 professionals and associates in more than 70 offices nationwide. McGladrey & Pullen is a licensed CPA firm, and is a member of RSM International, the sixth largest global network of independent accounting, tax and consulting firms. For more information, visit www.mcgladrey.com, join our Facebook fan page at McGladrey News, follow us on Twitter @McGladrey and/or connect with us on LinkedIn.